Each film-coated tablet contains: :
Mesterolone USP 25mg
Colour: Approved colour used in coang.
INDICATIONS AND USES:
Provi-25 balances a deficiency of androgen formaon which begins to fall gradually with increasing age. Therefore, Provi-25 is suitable for the treatment of all condions caused by deficient endogenous androgen formaon. In the recommended therapeuc dosage, Provi-25 will not impair spermatogenesis Provi-25 is especially well tolerated by the liver.
Carcinoma of the prostate, previous or exisng liver tumours. Hypersensivity to the acve substances or to any of the Excipient.
If, in individual cases, frequent or persistent erecons occur. The dose should be reduced or the treatment disconnued in order to avoid injury to the penis.
Androgens are not suitable for enhancing muscular development in healthy individuals or for increasing physical ability. Provironic is for use in male paents only . Regular examinaons of the prostate should be carried out prophylaccally.
DOSAGE AND ADMINISTRATION:
The concrete dosage will be defined by the physician. The usual adult dosage is 2 to 3 tabs per day.
Acute toxicity studies using single administraon showed that Provi 25 is to be classified as non-toxic. No risk of toxicity is to be expected even aer inadvertent single administraon of a mulple of the dose required for therapy.
2 blister strips of 25 tablets are packed in a printed carton along with a leaflet.
50 Tablets in Plasc Bole
Store at room temperature <25¡ã C, Protect from sunlight. Keep out of reach of children!